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THERE IS MUCH EVIDENCE to support
the idea that human tumours are able to
provoke humoral and cellular immune
responses. Supportive evidence includes
the histological appearance of draining
lymph nodes, in which follicular hyper-
plasia of B lymphocytes and enlargement
of T-lymphocyte areas are frequently
observed (Kaufmann et al., 1977). These
lymphocytes might have been stimulated
by the antigens of tumour cells, but the
precise antigenic specificities of these
lymphocytes remain to be elucidated. In
this respect, characterization of human
monoclonal antibodies produced by im-
mortalizinglymphocytesofregional lymph
nodes would answer the question concern-
ing B lymphocytes. A few hybrid cell lines
producing human monoclonal antibodies
specific to tumours have been developed
by fusing lymphocytes of lymph nodes
draining human tumours with murine
myeloma cells (Schlom et al., 1980; Sikora
& Wright, 1981). There is an alternative
method for producing human monoclonal
antibodies. Epstein-Barr virus (EBV)
transforms human B lymphocytes into
lymphoblastoid cells secreting immuno-
globulins. This property of EBV has been
applied by several investigators to the
production of specific antibodies in vitro
(Steinitz et al., 1977; Luzzanti et al., 1977).
An antibody against a human tumour-
associated oncofoetal antigen (OFA-I) was
also produced by transforming peripheral
blood lymphocytes of melanoma patients
(Irie et al., 1981). In this report, we
employed this method to immortalize the
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lymphocytes of lymph nodes draining
human lung cancers and analysed the
specificities of antibodies produced using
immunohistochemical methods.
An EBV-producing marmoset cell line,
B-95-8, was used as the source of EBV
(Miller & Lipman, 1973). B-95-8 cells were
seeded at a concentration of 3 x 105/ml in
the culture medium, which was RPMI-
1640 supplemented with 20% heat-inacti-
vated foetal bovine serum, 100 ml
penicillin and 100 [kg/ml of streptomycin,
and cultured at 37°C for 7 days. The
culture supernatants were separated by
centrifugation and passed through a Milli-
pore filter (pore size 0 45 am). The virus
stock was stored at > 80°C until use.
Hilar lymph nodes were obtained at
surgery from one case each of moderately
differentiated adenocarcinoma (Case 1)
and large-cell carcinoma (Case 2) of the
lung. The tumour of Case 1, which was
resected from a 69-year-old male, was
5 x 3-5 cm in size and hilar lymph nodes
showed metastases. The tumour of Case 2,
which was resected from a 55-year-old
male, was 2-5 x 2 cm in size and had also
metastasized to the hilar lymph nodes.
Non-tumorous regions of these lymph
nodes showed follicular hyperplasia histo-
logically. Single-cell suspensions were
prepared from such regions and were
resuspended in the culture medium at a
cell concentration of 1 x 107/ml, to which 2
volumes ofthe virus stock were added. The
mixture was shaken for 2 h at 37°C, and
diluted with the culture medium to obtain
a cell concentration of 1 x 105/ml. Then,
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TABLE I.-Immunohistochemical reaction pattern of antibodies against xenografted
tumours and murine tissues
Type Tumour xenografts
1 Adenocarcinoma (cell surface, linear
Fig. 1)
2 Large-cell carcinoma
Small-cell carcinoma (cytoplasm, diffuse)
3 Squamous-cell carcinoma
Adenocarcinoma (cytoplasm, granular)
4 All tumour xenografts (cytoplasm,
diffuse)
0-1 ml of the diluted cell suspension was
distributed to each well of 96-well tissue
culture plates. The plates were kept in a
humidified incubator at 37°C with 7% CO2
and halfthe medium was exchanged every
3-4 days.
During 4 weeks of culture, a small
number ofcolonies oflymphoblastoid cells
developed in each well. The cells in each
well were then transferred to each well of
24-well tissue culture plates, and 1-5 ml of
the culture medium was added. After an
additional 2 weeks of culture, culture
supernatants were individually screened
for the presence of antibody against
human lung cancer xenografts, which
consisted of one each of adenocarcinoma
(Lu-66), squamous-cell carcinoma (Lu-
61), small-cell carcinoma (Lu-i), and large-
cell carcinoma (Lu-116) (Shimosato et al.,
1979). The reason why we selected the
xenografted tumour as the target tissue of
screening is due to the difficulty ofstaining
human tissues with human antibodies. If
one stains human tissues with human
antibodies using anti-human immuno-
globulins as the second antibody in the
immunohistochemical method, endo-
genous human immunoglobulins in the
human tissues elicit some background
staining. In this respect xenografted tum-
ours, which are devoid ofhuman immuno-
globulins, are more suitable as the target
tissue.
Sections of formalin-fixed tissues con-
taining both xenografted tumours and
various organs of host nude mice were
immunohistochemically stained with the
culture supernatants. A 4-step immuno-
Mice
Renal distal tubule and loop of Henle (luminal
surface, linear)
Cilia of bronchial epithelium, peripheral nerve,
and mesangial cell (Fig. 3)
Squamous epithelium of oesophagus (cytoplasm,
granular)
Bronchial epithelium, muscle, and many other
cells (cytoplasm, diffuse)
FiG. 1. The first type of antibody immuno-
histochemically stained the surface of
xenografted adenocarcinoma, Lu-66.
Counterstained with haematoxylin. Bar
= 50 ,m.
peroxidase technique using peroxidase-
antiperoxidase complex as the final step
was applied (Sternberger, 1979). After
blocking the endogenous-peroxidase activ-
ity by incubating sections in methanol
containing 0.3% H202 for 30 min, they
were overlaid with culture supernatants
and kept for 2 h at room temperature and
overnight at 4°C. Control sections were
incubated with the fresh culture medium.
All sections were subsequently incubated
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FIG. 2. The first type of antibody stained Fig. 3.-The second type of antibody stained
the surface ofsome non-ciliated bronchiolar the cilia of bronchial epithelium (arrows)
cells of autologous lung. Counterstained and the peripheral nerves (N) of mice.
with haematoxylin. Bar= 50 [tm. Counterstained with haematoxylin. Bar=
50 ,um.
with rabbit anti-human immunoglobulins,
diluted 1:100, swine anti-rabbit immuno-
globulins, diluted 1: 20, and rabbit per-
oxidase-antiperoxidase complex, diluted
1:50, for 30 min. Then the sections were
developed for 5-10 min in 0-05M Tris HCl,
pH 7-6, containing 0.02% 3,3'-diamino-
benzidine and 0.005% H202. Finally,
the sections were counterstained with
haematoxylin.
Four of 24 wells in Case 1 and 7/24 wells
in Case 2 contained antibodies which
clearly reacted with the human lung
cancer xenografts, but these antibodies
also reacted with some normal cells of
mice. These antibodies were divided into 4
types depending upon their staining pat-
tern (Table I, Figs 1, 3). In addition, a few
wells contained antibodies which reacted
with erythrocytes or leucocytes of mice,
but not with human lung cancer xeno-
grafts.
The monoclonality ofthe antibodies was
shown by examining the immunoglobulin
class of heavy and light chains of the
antibodies. The second antibody in the 4-
step immunoperoxidase technique was
substituted by rabbit anti-human IgM,
anti-human IgG, anti-human K, or anti-
human A immunoglobulins. This analysis
revealed that the antibodies were IgM and
possessed a single light chain.
Finally, autologous human lung cancers
and surrounding non-involved lung tis-
sues were stained with these antibodies
immunohistochemically. Use of rabbit
anti-human IgM, diluted 1:1000, made it
possible to stain human tissues without
significant background staining. The 4
types of antibodies more or less reacted
with autologous tumour cells with a
staining pattern similar to that of xeno-
grafted tumours (Fig. 4). However, they
also reacted with some normal cells in
autologous humanlungs (Table II, Fig. 2).
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FIG. 4.-The second type of antibody stained
the cytoplasm of autologous tumour cells
diffusely. Counterstained with haemato-
xylin. Bar=50 ,um.
TABLE II Immunohi8tochemical reaction
pattern of antibodies a yainstautoloous
human lung tissues
Type Human lung tissues
1 Non-ciliated bronchiolar cell (cell
surface, linear Fig. 2)
2 Cilia of bronchial epithelium
Peripheral nerve
3 Bronchial epithelium (cytoplasm,
granular)
4 Bronchial and alveolar epithelium
(cytoplasm, diffuse)
In this study, we demonstrated clearly
that human antibodies reactive with
human lung cancers could be produced in
vitro by EBV transformation of lympho-
cytes in draining lymph nodes of lung
cancers. However, the antibodies obtained
were not tumour-specific, because they
reacted with some normal cells of human
lungs. In addition they were heterophilic,
because they reacted with some normal
cells of mice. From these findings, it is
concluded that in the draining lymph
nodes some B lymphocytes are present
which react with both neoplastic cells and
autologous and heterologous normal cells.
It has been considered that lymphocyte
proliferation in the regional lymph nodes
may be induced by tumour-specific anti-
gens (Kaufmann et al., 1977). However,
our data so far support the possibility that
some B lymphocytes in the regional lymph
nodes were stimulated not by the tumour-
specific antigens but by the antigens
commonly present in both neoplastic and
normal cells.
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